• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: arimoclomol citrate
Date Designated: 01/13/2015
Orphan Designation: Treatment of Neimann-Pick disease, type C
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Zevra Denmark A/S
Ole Maaloes Vej 3
Copenhagen, København 2200

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.